Normalized Income after Taxes: A company's after tax profit or loss smoothed out by elimination of all non-recurring items.
Oxford BioMedica (OXBDF) Normalized Income after Taxes data is not available.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
|
Normalized Income after Taxes |
-- |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$149.59M |
|
$62.81M |
|
$95.98M |
|
$245.56M |
|
$79.12M |
|
$114.43M |
|
$129.29M |
|
$208.41M |
|
$37.15M |
|
$9.55M |
|
$37.15M |
|
106.14M |
|
| Cash Flow Statement Financials | |
$4.12M |
|
$-0.27M |
|
$-11.53M |
|
$68.85M |
|
$61.16M |
|
$-7.69M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|